SCHEMBL1123563

SCHEMBL1123563

COC(=O)c1ccc(OCCNCc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.68
RAB9A P51151 3/20 0.68
DRD4 P21917 2/20 0.65
KMT2A Q03164 2/20 0.64
KDM4E B2RXH2 2/20 0.60
LMNA P02545 1/20 0.60
MITF O75030 1/20 0.60
GAA P10253 1/20 0.60
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
NPC1 O15118 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
PPARG P37231 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
LTA4H P09960 1/20 0.55
MEN1 O00255 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20249539 0.95 LTA4H (0.64) MAPTRAB9ADRD4KMT2AKDM4E
SCHEMBL8042114 0.86 MAPT (0.77) MAPTRAB9ADRD4KMT2AKDM4E
SCHEMBL9268670 0.86 DRD4 (0.69) MAPTDRD4KMT2AKDM4ELMNA
SCHEMBL1122816 0.85 DRD4 (0.64) MAPTRAB9ADRD4KMT2AKDM4E
SCHEMBL11544699 0.84 OPRM1 (0.67) DRD4KMT2AKDM4ELMNAMITF
SCHEMBL4361298 0.82 MAPT (0.77) MAPTRAB9AKMT2AKDM4ECA1
Hydrochloric Acid SCHEMBL10366145 0.82 DRD4 (0.63) DRD4KMT2AKDM4ELMNAMITF
SCHEMBL5284759 0.82 MAPT (1.00) MAPTRAB9AKMT2AKDM4ELMNA
SCHEMBL3746846 0.82 SMN1; SMN2 (0.73) MAPTRAB9AKMT2ALMNACA1
SCHEMBL20249537 0.82 LTA4H (0.55) MAPTRAB9ADRD4KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
CN-1835914-A New benzamides as PPAR[upsilon] modulators S A L V A T LAB SA (ES) 2006-09-20 CN disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed
EP-1644321-A2 NEW BENZAMIDES AS PPATY MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-04-12 EP disclosed
WO-2004110983-A2 NEW BENZAMIDES AS PPARϒ MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG MAPT 4365/4885RAB9A 4567/4885DRD4 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.